Medical Weight Loss for Fremont, Nebraska Residents
Fremont, Nebraska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Fremont through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Fremont Residents Choose New Hope Weight Loss
Fremont patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Nebraska and beyond since 2020.
From our Costa Mesa, California practice, we provide Fremont with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
For Fremont, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout downtown Fremont and the greater Dodge County area near Omaha. There is no distance surcharge for Fremont patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Telehealth removes the distance between Fremont and specialized care: your consultation happens wherever you are in Nebraska. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Fremont patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Fremont
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Fremont
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Fremont address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Fremont
Is there a medical weight loss clinic near Fremont?
Our physical clinic is in Costa Mesa, California. We serve Fremont, Nebraska residents through telehealth, the same physician care from Dr. Sharma by secure video, with compounded medication shipped to your address. Telehealth eligibility is confirmed during the consultation.
Do I need to visit in person from Fremont?
No. We offer full telehealth consultations. Your physician review, prescription, and ongoing support are all handled remotely, with compounded medication shipped to your Fremont address in cold-pack packaging.
How much does treatment cost for Fremont patients?
The same as for every patient nationwide: a $119 physician visit, compounded semaglutide from $166/month (a 90-day program is $499), and compounded tirzepatide from $233/month. Medication is billed separately. HSA and FSA are accepted; Klarna and Affirm are available. There is no distance surcharge.
What areas of Fremont do you serve?
We serve patients from across Fremont by telehealth, including downtown Fremont and the greater Dodge County area near Omaha.
What support is there for side effects for Fremont patients?
Dr. Sharma starts Fremont patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Fremont, Nebraska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.